Position in SNY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$78,707
-$13,316 QoQ
Shares Held
1,845
-3.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#518
of 712 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CHELSEA COUNSEL CO holds $9,679,558 across 10 Drug Manufacturers - General names. SNY ranks #7 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
17,904 | $4,547,078 | |
| 2 | AMGN |
Amgen Inc
|
8,954 | $3,242,422 | |
| 3 | GSK |
GSK plc
|
9,360 | $490,651 | |
| 4 | PFE |
Pfizer Inc
|
20,000 | $481,600 | |
| 5 | LLY |
ELI LILLY & Co
|
351 | $420,999 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,840 | $364,940 | |
| 7 | SNY |
Sanofi
This page
|
1,845 | $78,707 | |
| 8 | ABBV |
AbbVie Inc.
|
114 | $28,686 |
All Filings in SNY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $78,707 | 1,845 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $92,023 | 1,910 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $92,558 | 1,910 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $648,764 | 13,745 | Shares | Sole | 2025-11-25 | |
| 2025-06-30 | $688,175 | 14,245 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $815,816 | 14,710 | Shares | Sole | 2025-05-22 | |
| 2024-12-31 | $715,492 | 14,835 | Shares | Sole | 2025-02-27 | |
| 2024-09-30 | $914,011 | 15,860 | Shares | Sole | 2024-11-21 | |
| 2024-06-30 | $771,953 | 15,910 | Shares | Sole | 2024-11-21 | |
| No filing history on record for this holder in this stock. | ||||||